Publications by authors named "Brian Betts"

Claim this Profile
I
ICANS and mortality after CAR-T therapy for NHL patients can be predicted using physical function measures of falls, balance and strength deficits, and use of an assistive device.
Nisha M Nair, Theresa E Hahn, Hillary Jacobson, Shernan Holtan, Marco L Davila, Brian Christopher Betts

Bone Marrow Transplant· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIGHER HLA-DRB1 EVOLUTIONARY DIVERGENCE (HED) IS ASSOCIATED WITH REDUCED RELAPSE AND IMPROVED SURVIVAL AFTER MATCHED UNRELATED HEMATOPOIETIC CELL TRANSPLANTATION.
Jennifer N Saultz, Yung-Tsi Bolon, Tao Wang, Steve Spellman, Stephanie Lee, Brian C Betts

Transplant Cell Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Choosing Between HLA-Mismatched Unrelated and Haploidentical Donors: Donor Age Considerations.
Rohtesh S Mehta, Gabrielle Schmidt, Kirsten Williams, Shyam A Patel, Johannes Schetelig, Brian Betts

Transplant Cell Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 infection drives local inflammation of the intestinal epithelium in immunocompromised patients with cancer.
Emil Lou, Christine Luo, Katherine Ladner, Allison Makovec, Phillip Wong, Brian Betts

iScience· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transplant outcomes using older matched sibling donors compared with young alternative donors: a CIBMTR analysis.
Karthik Nath, Mei-Jie Zhang, Matthew Bye, Muhammad Bilal Abid, Cara Benjamin, Brian Betts

Blood Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK2/mTOR inhibition fails to prevent acute GVHD despite reduced Th1/Th17 cells: final phase 2 trial results.
Joseph Pidala, Shernan G Holtan, Kelly Walton, Jongphil Kim, Biwei Cao, Brian C Betts

Blood· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Scoring System for Ranking Hematopoietic Stem Cell Transplantation.
Lee Ann Baxter-Lowe, Tao Wang, Michelle Kuxhausen, Stephen R Spellman, Martin Maiers, Brian C Betts

Clin Transplant· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular biomarkers reveal a unique toxicity profile of posttransplant cyclophosphamide: secondary analysis of BMT CTN 0402 and 1202.
Laura F Newell, Najla El Jurdi, Brian C Betts, Corey Cutler, Joseph H Antin

Blood Vessel Thromb Hemost· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Human Leukocyte Antigen-Matched Related Donor and Haploidentical Allogeneic Hematopoietic Cell Transplantation Recipients by Immune Profiles of Recipients and Donors.
Megan M Herr, Sophia R Balderman, Paul K Wallace, Yali Zhang, Joseph D Tario, Brian Betts

Transplant Cell Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD.
Aaron Etra, Najla El Jurdi, Nikolaos Katsivelos, Deukwoo Kwon, Stephanie Gergoudis, Brian C Betts

Blood Adv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amphiregulin as a biomarker for monitoring lifethreatening acute graft--host disease: secondary analysis of two prospective clinical trials.
Shernan G Holtan, Najla El Jurdi, Armin Rashidi, Brian C Betts, Connor Demorest

Haematologica· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia.
Justin C Boucher, Bishwas Shrestha, Paresh Vishwasrao, Mark Leick, Estelle V Cervantes, Brian C Betts

Mol Ther Oncolytics· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-transplant and longitudinal changes in faecal microbiome characteristics are associated with subsequent development of chronic graft-versus-host disease.
Najla El Jurdi, Shernan G Holtan, Andrea Hoeschen, Jessica Velguth, Benjamin Hillmann, Brian C Betts

Br J Haematol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Myeloablative 7-8/8-Matched Allotransplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil.
Najla El Jurdi, Alex Hoover, Daniel O'Leary, Qing Cao, Ashish Gupta, Brian C Betts

Transplant Cell Ther· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II, Open-Label Clinical Trial of Urinary-Derived Human Chorionic Gonadotropin/Epidermal Growth Factor for Life-Threatening Acute Graft-versus-Host Disease.
Shernan G Holtan, Andrea Hoeschen, Qing Cao, Celalettin Ustun, Brian C Betts

Transplant Cell Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK-STAT inhibition reduces endothelial prothrombotic activation and leukocyte-endothelial proadhesive interactions.
Joan D Beckman, Angelica DaSilva, Elena Aronovich, Aithanh Nguyen, Julia Nguyen, Brian Betts

J Thromb Haemost· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sarcopenia Predicts Inferior Progression-Free Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation.
Nuttavut Sumransub, Qing Cao, Mark Juckett, Brian Betts, Shernan Holtan

Transplant Cell Ther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality.
Shernan G Holtan, Constanza Savid-Frontera, Kelly Walton, Anne A Eaton, Connor Demorest, Brian C Betts

Clin Cancer Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in GVHD Risk Without Increased Relapse Risk Compared to Historical Cyclosporine/Methotrexate.
Najla El Jurdi, Alex Hoover, Daniel O'Leary, Qing Cao, Ashish Gupta, Brian C Betts

medRxiv· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High cutaneous amphiregulin expression predicts fatal acute graft-versus-host disease.
Brittney Schultz, Daniel D Miller, Todd DeFor, Bruce R Blazar, Angela Panoskaltsis-Mortari, Brian C Betts

J Cutan Pathol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors and outcomes of flares in chronic graft-versus-host disease.
Najla El Jurdi, Grigori Okoev, Todd E DeFor, Shernan G Holtan, Brian C Betts

Bone Marrow Transplant· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual JAK2/Aurora kinase A inhibition prevents human skin graft rejection by allo-inactivation and ILC2-mediated tissue repair.
Kelly Walton, Kirsti Walker, Megan Riddle, Brent H Koehn, Jordan Reff, Brian C Betts

Am J Transplant· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of CD34 Cell Dose with 5-Year Overall Survival after Peripheral Blood Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies.
Timothy D Gauntner, Claudio G Brunstein, Qing Cao, Daniel Weisdorf, Erica D Warlick, Brian C Betts

Transplant Cell Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease.
Aleksandr Lazaryan, Stephanie Lee, Mukta Arora, Jongphil Kim, Brian Christopher Betts

Blood Adv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Objective and subjective physical function in allogeneic hematopoietic stem cell transplant recipients.
Asmita Mishra, Joseph Pidala, Ram Thapa, Brian C Betts, Hugo Fernandez

Bone Marrow Transplant· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis